UPDATE : Tuesday, March 20, 2018
Lundbeck to test antidepressant on Korean teenagers
Lundbeck Korea said it would conduct a phase-3 clinical trial on antidepres...
by Lee Hye-seon  |  2018-01-19 15:11
New local prescription drugs performed well in 2017
Novel drugs developed by domestic pharmaceutical companies achieved substan...
by So Jae-hyeon  |  2018-01-19 13:46
GSK Korea’s head named to lead GSK Canada
GlaxoSmithKline (GSK) Korea said Friday that Hong Yoo-seok, head of GSK’s K...
by Marian Chu  |  2018-01-19 11:41
Dong-A ST, NeuroBo Pharmaceuticals announce license agreement
Dong-A ST said Thursday that it has signed a license agreement with NeuroBo...
by Lee Han-soo  |  2018-01-18 16:05
CJ Healthcare hits record sales for Anfrade
CJ Healthcare said Thursday that it hit record outpatient prescription sale...
by Lee Han-soo  |  2018-01-18 15:30
Gilead Sciences’ Viread records highest prescription sales in Korea last year
Gilead Sciences’ Viread recorded the highest prescription sales in Korea, r...
by Marian Chu  |  2018-01-18 15:10
GC Pharma to proceed with P2/3 trial for hepatitis B immunoglobulin
GC Pharma, formerly known as Green Cross, said Thursday it has received app...
by Lee Han-soo  |  2018-01-18 11:28
Pfizer Korea recorded most drug recalls in 2017
Pfizer Korea recorded the largest number of drug recalls and disposals amon...
by So Jae-hyeon  |  2018-01-17 13:36
Merck’s Keytruda extends lung cancer survival in pivotal P3 trial
Merck & Co (known as MSD outside the U.S. and Canada) said Tuesday that a K...
by Marian Chu  |  2018-01-17 12:11
Novartis’ Cosentyx beats out Stelara in 2nd head-to-head trial
Novartis’ plaque psoriasis drug Cosentyx (secukinumab) showed superiority t...
by Marian Chu  |  2018-01-17 11:10
Medtronic elects Chris Lee as new Asia-Pacific chief
Medtronic said Tuesday it appointed Chris Lee as the president of its Asia ...
by Marian Chu  |  2018-01-16 11:15
Huons to upgrade facility to target global eye drop market
Huons, a subsidiary of Huons Global, said Monday that it would enhance its ...
by Lee Han-soo  |  2018-01-15 16:21
Hanmi 1st for R&D investment among Korean pharmas
Hanmi Pharmaceuticals invested the most in research and development among K...
by Marian Chu  |  2018-01-15 15:22
Competition heats up in hair loss treatment market
Local drugmakers are increasingly competing to sell over-the-counter (OTC) ...
by So Jae-hyeon  |  2018-01-15 15:02
Hepatitis C drug Mavyret arrives in Korea
Abbvie’s hepatitis C treatment Mavyret (ingredient: glecaprevir/pibrentasvi...
by Lee Hye-seon  |  2018-01-15 11:19
Gaucher disease drug effective for retention, early treatment, Sanofi says
Sanofi Genzyme emphasized the convenience of Cerdelga (Ingredient: eligusta...
by Nam Doo-hyun  |  2018-01-15 10:27
AstraZeneca gets expanded FDA approval for cancer drug
The U.S. Food and Drug Administration said Friday it approved AstraZeneca’s...
by Marian Chu  |  2018-01-15 10:20
Daewoong gets approval to start Nabota BTX clinical trials in China
Daewoong Pharmaceutical is making inroads into the Chinese market with its ...
by Marian Chu  |  2018-01-11 16:24
Drugmakers work on ‘me-too’ drugs of Pradaxa
Hanmi Pharmaceutical, Ahngook Pharmaceutical, Dasan Medichem, and Huons are...
by Lee Hye-seon  |  2018-01-11 16:12
Hanmi slates US-based phase 1 trial for LAPSTriple Agonist: CEO
Hanmi Pharmaceutical is ramping up efforts to enter the global market with ...
by Marian Chu  |  2018-01-11 15:59
Back to Top